how many people are taking glp-1 for weight loss Poll: 1 in 8 Adults Say They Currently a Drug Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford Taking weight-loss drugs means eating

By defining stages from no residue to severe obstruction, it enhances study comparisons and procedure planning while promoting a shared understanding among providers

Some days you feel nauseous at the sight of food, and on others you forget to eat entirely

The Australia GLP-1 receptor agonist market size was valued at USD 570.49 million in 2025 and is expected to hit around USD 2,117.46 million by 2035, growing at a CAGR of 14.01% from 2026 to 2035.

This infographic breaks down these drugs by active ingredients, brand names and approved uses of popular GLP-1s.

Disclaimer: These statements have not been evaluated by the FDA

Weekly Meal Planner